This international congress aims to gather scientific, pharmaceutical and clinical researchers to share and discuss the latest achievements and hot topics on the mechanisms by which the immune system and the pancreas contribute to the development of type 1 diabetes (T1D), and on the translation of this information into more effective therapies for T1D. Attendees will hear renowned speakers exposing the challenges and opportunities facing the T1D field, with state-of-the-art oral and poster presentations covering the most recent technical and scientific advances on the disease pathophysiology and treatment. Cutting-edge findings in viral or tumor immunology will further nurture and complement dynamic exchanges and ideas.

Early bird registration deadline: Feb 15th 2023

Final registration deadline: March 15th 2023

Abstract submission deadline: Feb 15th 2023

For further information, please visit the Congress website, regularly updated: